Medtronic, Inc. (NYSE: MDT) announced Tuesday that it has reached a global patent settlement agreement with Edwards Lifesciences Corporation (NYSE ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE